The emerging therapeutic potential of botulinum toxin in cardiology

Heart Rhythm. 2022 Dec;19(12):2105-2106. doi: 10.1016/j.hrthm.2022.08.032. Epub 2022 Sep 6.

Authors

Jonathan S Steinberg¹, Alexander Romanov²

Affiliations

¹ Clinical Cardiovascular Research Center, University of Rochester School of Medicine & Dentistry, Rochester, New York. Electronic address: Jonthan.Steinberg@heart.rochester.edu.
² Meshalkin National Medical Research Center, Novosibirsk, Russian Federation.

PMID: 36075531
DOI: 10.1016/j.hrthm.2022.08.032

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Botulinum Toxins, Type A* / therapeutic use
Cardiology*

Substances

Botulinum Toxins, Type A

Grants and funding

R34 HL153579/HL/NHLBI NIH HHS/United States